Trial Profile
A Pilot Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2024
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- 01 Apr 2024 Planned initiation date changed from 1 Apr 2024 to 1 Jun 2024.
- 09 Feb 2024 New trial record